Literature DB >> 34091232

Body mass and the epidemic of chronic inflammation in early mid-adulthood.

Thomas W McDade1, Jess M Meyer2, Stephanie M Koning3, Kathleen Mullan Harris4.   

Abstract

OBJECTIVES: Chronic inflammation is a potentially important mechanism through which social inequalities may contribute to health inequalities over the life course. Excess body fat contributes to chronic inflammation, and younger adults in the US have come of age during a pronounced secular increase in body mass index (BMI). We aim to document levels of chronic inflammation in a nationally representative sample of 33-to-44 year-old adults in the US, and to describe associations with BMI, race/ethnicity, and education.
METHODS: High sensitivity C-reactive protein (CRP) was measured in Wave V (2016-18) of the National Longitudinal Study of Adolescent to Adult Health, with complete data available for 4349 participants. Sex-stratified weighted regression models were implemented to investigate CRP in association with education, race/ethnicity, and BMI.
RESULTS: Geometric mean CRP was 1.9 mg/L, and 35.4% of the sample had CRP >3 mg/L. Females had significantly higher CRP than males. Body mass index was a strong positive predictor of CRP, and education level was negatively associated with CRP. Associations between education and CRP were substantially attenuated after adjusting for BMI. High risk CRP increased linearly with BMI even among the obese: 87.0 percent of females and 74.1 percent of males with class 3 obesity (BMI ≥40) were predicted to have high risk CRP > 3 mg/L.
CONCLUSIONS: The obesity epidemic is producing an epidemic of chronic inflammation in early mid-adulthood in the US. Strong associations between BMI and chronic inflammation portend high risk for future disease-and inequitable distribution of disease-as the cohort ages.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C-reactive protein; Education; Health disparities; Obesity; Overweight

Mesh:

Substances:

Year:  2021        PMID: 34091232      PMCID: PMC8259331          DOI: 10.1016/j.socscimed.2021.114059

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   5.379


  25 in total

1.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  Trends in Cardiometabolic Mortality in the United States, 1999-2017.

Authors:  Nilay S Shah; Donald M Lloyd-Jones; Martin O'Flaherty; Simon Capewell; Kiarri N Kershaw; Mercedes Carnethon; Sadiya S Khan
Journal:  JAMA       Date:  2019-08-27       Impact factor: 56.272

Review 3.  Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis.

Authors:  Yunwei Li; Xiaoming Zhong; Guanchang Cheng; Cuihua Zhao; Lei Zhang; Yan Hong; Qilin Wan; Ruili He; Zhizhong Wang
Journal:  Atherosclerosis       Date:  2017-02-09       Impact factor: 5.162

4.  Adolescent BMI trajectory and risk of diabetes versus coronary disease.

Authors:  Amir Tirosh; Iris Shai; Arnon Afek; Gal Dubnov-Raz; Nir Ayalon; Barak Gordon; Estela Derazne; Dorit Tzur; Ari Shamis; Shlomo Vinker; Assaf Rudich
Journal:  N Engl J Med       Date:  2011-04-07       Impact factor: 91.245

5.  Do birth cohorts matter? Age-period-cohort analyses of the obesity epidemic in the United States.

Authors:  Eric N Reither; Robert M Hauser; Yang Yang
Journal:  Soc Sci Med       Date:  2009-09-19       Impact factor: 4.634

6.  Obesity in adolescence and adulthood and the risk of adult mortality.

Authors:  Anders Engeland; Tone Bjørge; Aage Tverdal; Anne Johanne Søgaard
Journal:  Epidemiology       Date:  2004-01       Impact factor: 4.822

7.  The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates.

Authors:  Ryan K Masters; Eric N Reither; Daniel A Powers; Y Claire Yang; Andrew E Burger; Bruce G Link
Journal:  Am J Public Health       Date:  2013-08-15       Impact factor: 9.308

8.  Birth cohort effects among US-born adults born in the 1980s: foreshadowing future trends in US obesity prevalence.

Authors:  W R Robinson; K M Keyes; R L Utz; C L Martin; Y Yang
Journal:  Int J Obes (Lond)       Date:  2012-05-01       Impact factor: 5.095

9.  Early origins of socioeconomic inequalities in chronic inflammation: Evaluating the contributions of low birth weight and short breastfeeding.

Authors:  Thomas W McDade; Stephanie M Koning
Journal:  Soc Sci Med       Date:  2020-12-08       Impact factor: 4.634

10.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.

Authors:  Stephen Kaptoge; Emanuele Di Angelantonio; Gordon Lowe; Mark B Pepys; Simon G Thompson; Rory Collins; John Danesh
Journal:  Lancet       Date:  2009-12-22       Impact factor: 79.321

View more
  3 in total

1.  Does body mass index explain the apparent anti-inflammatory effects of cannabis use? Results From a cohort study of sexual and gender minority youth.

Authors:  Joshua M Schrock; Thomas W McDade; Richard T D'Aquila; Brian Mustanski
Journal:  Drug Alcohol Depend       Date:  2022-02-03       Impact factor: 4.492

2.  The Neutrophil-Lymphocyte Ratio Is Positively Correlated with Aggression in Schizophrenia.

Authors:  Zhu Tong; Jing Zhu; Jia-Jia Wang; Yu-Jing Yang; Wei Hu
Journal:  Biomed Res Int       Date:  2022-04-23       Impact factor: 3.246

3.  Older Adults in the United States Have Worse Cardiometabolic Health Compared to England.

Authors:  Benedetta Pongiglione; George B Ploubidis; Jennifer B Dowd
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2022-05-27       Impact factor: 4.942

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.